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Abstract
Background: Ma-Xing-Gan-Shi-Tang (abbreviated as MXGST), an important Chinese herbal prescribed for cough,
bronchial inflammation and fever from pneumonia, consists of four medicinal herbs, including Ephedrae herb,
Semen Pruni Armeniacae, licorice and Gypsum. These components, especially Ephedrae and Semen Pruni
Armeniacae, possess antitussive activities, but they have severe adverse effects.
Methods: The pharmacological activities of MXGST extract in clinical use were investigated with citric acid-induced
cough, acetylcholine/histamine-induced bronchial contraction and lipopolysaccharide (LPS)-induced fever in
rodents. The subacute toxicology of MXGST extract was evaluated after a 28-day repeated oral administration
in rats.
Results: Each gram of MXGST extract contained 60 ± 8 μg of ephedrine, 480 ± 40 μg of glycyrrhizic acid and
440 ± 8 μg of amygdalin according to high performance liquid chromatography and a photodiode array
detector. MXGST extract produced pronounced, dose-dependent antitussive effects in guinea pigs and
reduced hyperthermic syndrome induced by LPS in rats. MXGST extract blocked the bronchial contraction
induced by acetylcholine/histamine. Oral administration of MXGST extract for 28 days did not cause any
hematological, biochemical or histological changes in rats.
Conclusions: MXGST extract is a safer, more effective Chinese prescription with antitussive and anti-pyretic
effects. The antitussive mechanism of MXGST is related to partially relaxing the bronchial smooth muscle by
blocking acetylcholinergic and histaminergic receptors.
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Background
Cough is a beneficial, important protective reflex against ir-
ritants or foreign materials, and coughing helps keep the re-
spiratory tract clear. However, cough is a primary symptom
of respiratory illness with a high worldwide incidence. It is
not only a common symptom of lung diseases, such as
upper respiratory tract infection, it is one of the most com-
mon complaints that diminishes the patient’s comfort and
causes sleep disturbances [1, 2]. Based on the physiological
mechanism of the medulla oblongata controlling the
coughing reflex, centrally acting antitussive drugs, such as
codeine and dextromethorphan, were developed, but their
clinic utility has been limited by their undesirable and in-
tolerable side effects such as sedation, nausea, addictive po-
tential and constipation [3, 4]. Therefore, the discovery of
novel, safe and effective antitussive agents for treating
cough could be facilitated by investigating medicinal plants
or herb prescriptions. Ma-Xing-Gan-Shi-Tang (abbreviated
as MXGST), an important Chinese herbal medicine for
treating cough and fever from pneumonia, consists of
Ephedrae (the stem of Ephedra intermedia), Semen Pruni
Armeniacae (the semen of Prunus armeniaca), licorice (the
roots of Glycyrrhiza uralensis), and Gypsum [5]. Pharmaco-
logical reports have indicated that MXGST possesses anti-
asthmatic and anti-pyretic activities in allergy-induced or
ovalbumin-induced rodent bronchial inflammation models
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and a rabbit fever model [6–10]. Its major component,
Ephedrae, a plant containing multiple active alkaloids, pos-
sesses antitussive and anti-asthmatic activities and has been
used to treat upper respiratory tract infection or asthma for
decades. However, Ephedrae prescriptions are restricted by
the US Food and Drug Administration due to their cardio-
vascular and CNS stimulatory adverse effects, which result
from its principal alkaloid ephedrine, a sympathomimetic
agonist at α- and β-adrenergic receptors [11, 12]. The sec-
ond important component Semen Pruni Armeniacae also
possesses antitussive activities via its major ingredient
amygdalin which biotransformed into cyanide. However,
the therapeutic index of cyanide is very narrow and cyanide
intoxication can occur [13, 14]. Therefore, the present study
attempted to investigate the antitussive and anti-pyretic ef-
fects of MXGST extract in rodents with citric acid-induced
cough [15] and lipopolysaccharide (LPS)-induced hyper-
thermia [16]. Then, we further investigated the antitussive
mechanism of MXGST extract using acetylcholine/hista-
mine-induced bronchial contraction in guinea pigs. Fur-
thermore, we performed a 28-day repeated oral subacute
toxicology test of MXGST extract because the major com-
ponents of MXGST extract, including Ephedrae, Semen
Pruni Armeniacae and licorice have toxicological reports in
animal and clinical application [11–14, 17–20].
Methods
Preparation of plant extract
Ephedrae (TWU-Plantec-MXGST-0001), Semen Pruni
Armeniacae (TWU-Plantec-MXGST-0002), licorice
(TWU-Plantec-MXGST-0003) and Gypsum (TWU-
Plantec-MXGST-0004) were purchased from the
Taiwan market and identified by Professor Lin Y. C.
using macroscopic and microscopic methods. These
medicinal materials were deposited in the Department
of Medicinal Botanicals and Health Applications,
DaYeh University. MXGST (8.5 kg) consisted of the
aforementioned medicinal materials at a ratio of
4:3:2:8. They were cut into thin slices and place into a
container (100 × 100 × 100 cm3). Then, distilled water
was added and heated at 100 °C for 60 min. The solu-
tion was concentrated and dried with a rotary evapor-
ator (Laborota 20 compact, Heidolph Instruments
GmbH & Co. (Schwabach, Germany)) at 50 °C and
120–180 mbar. MXGST extract (459 g, 5.4 % yield)
was ground into powder, and sealed in a Pyrex glass
bottle. The ephedrine, glycyrrhizic acid and amygdalin
levels in MXGST extract were approximately 60 ± 8,
480 ± 40 and 440 ± 8 μg/g dry weight, which is in ac-
cordance with the calibration curve of ephedrine, gly-
cyrrhizic acid and amygdalin determined by high
performance liquid chromatography and a photodiode
array detector at 254 and 214 nm. The validation pa-
rameters of ephedrine, glycyrrhizic acid and amygdalin
are shown in Table 1.
MXGST extract (0.2, 0.4, 1.0 and 2.0 g/kg) was dis-
solved in sterile distilled water and administered or-
ally 120 min prior to the injection of an inducer. The
control was treated with sterile distilled water in the
same experiments. Aminophylline (125 mg/kg) was
prepared as a suspension with 0.5 % carboxymethyl-
cellulose and administered orally 30 min prior to the
injection of an inducer.
Animals
Male Sprague-Dawley rats (200–250 g) were used in
an LPS-induced hyperthermic test and 28-day re-
peated oral subacute toxicity test. Male guinea pigs
(150–200 g) were used in citric acid-induced cough
test. The experimental protocol (Protocol No. 102-
103-NH) was approved by the Institutional Animal
Care and Use Committee (IACUC) of China Medical
University and animal care was performed according
to the Guiding Principles for the Care and Use of La-
boratory Animals. The animals were housed for at
least 1 week before starting the experiment in a
temperature-(23 ± 1 °C) and humidity-(60 %) regulated
environment; they had with free access to standard
food in pellets and tap water on a 12–12 h light/dark
cycle (light phase: 08:00–20:00 h). After 1 week of
acclimatization, eight rodents in each group of the
below experiments were used. Then, the drugs were
administered and antitussive and anti-pyretic assays
were performed using a double-blind method. After
behavioral measurement, all animals were killed with
carbon dioxide.
Citric acid-induced cough in guinea pigs
Cough was induced by inhalation of 17.5 % citric acid
aerosol, which has been shown to induce the cough
reflex in guinea pigs [15]. The aerosol was adminis-
tered to animals via a small-volume ultrasonic
nebulizer that was connected to the bias flow port im-
mediately before the exposure chamber inlet. A
Table 1 Validation parameters for ephedrine, glycyrrhizic acid and amygdalin by high performance liquid chromatography
Compound Concentration range (μg/mL) R2 Linear regression Intra-D (%) Inter-D (%)
Ephedrine 6.25–100 0.997 Y = 0.454x-0.0356 1.00–2.74 0.98–3.02
Glycyrrhizic acid 6.25–100 0.999 Y = 0.052x + 0.0046 0.34–3.76 0.62–2.84
Amygdalin 6.25–100 0.990 Y = 0.0645x + 0.0788 1.61–4.33 1.48–3.67
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volume of 5 mL of citric acid solution was placed into
the ultrasonic nebulizer. During the 5-min aerosoliza-
tion period, approximately 0.4 mL of the solution was
nebulized. The onset and frequency of cough during
15 min (aerosolization time + observation time) were
recorded.
Acetylcholine/histamine-induced bronchial contraction in
guinea pigs
To explore the antitussive mechanism of MXGST extract,
guinea pigs were placed in a glass chamber (3 L volume)
and sprayed with a mixture of 0.1 % histamine and 2 %
acetylcholine chloride (1:1, v/v) for 15 s. The onset of re-
spiratory distress and tumble (pre-convulsive time) were re-
corded. The guinea pigs with a pre-convulsive time of more
than 120 s were considered insensitive and were discarded.
The eligible guinea pigs were randomly divided into five
groups, normal, three doses of MXGST extract (0.2, 0.4
and 1.0 g/kg) and aminophylline (125 mg/kg). The pre-
convulsive times for each guinea pig within 6 min were
observed.
LPS-induced hyperthermia in rats
The anti-pyretic activity of MXGST extract was evalu-
ated against LPS-induced hyperthermia in rats [16].
Fever was induced by intraperitoneal injection of
10 mL/kg of 100 μg/kg LPS. The rectal temperature
was recorded using clinical thermometer immediately
before MXGST treatment and immediately before and
1–6 h after LPS injection. Prior to the experiment, the
rats were maintained in separate cages for 7 days and
the animals with an approximately constant rectal
temperature were selected for the study.
Subacute toxicity study in the rats
The 28-day repeated oral toxicity studies were per-
formed in rats according to the OECD test guideline
407 [21]. Rats were randomly divided into 4 groups of
8 animals each. After an overnight fast, group 1 re-
ceived sterile distilled water, while groups 2–4 in-
cluded rats that received MXGST extract at doses of
0.4, 1.0 and 2.0 g/kg body weight, respectively.
MXGST extract were administered daily by oral gav-
age in the volume of 10 mL/kg body weight, once daily
for 28 days. The rats were observed daily for any ab-
normal clinical signs and death during the study
period. Body weight and food intake were measured
and recorded daily during the study period. At the end
of the study, all animals were fasted overnight. The
animals were weighed. Blood was collected using the
retro-orbital technique with or without ethylenedi-
aminetetraacetic acid (EDTA) for hematological and
biochemical analyses, respectively. The animals were
sacrificed and body organs, including the lung, liver
and kidney, were removed for detailed weight and
histopathological changes.
Hematological parameters and biochemical estimations
Red blood cells (RBCs), white blood cells (WBCs),
hematocrit (HCT), hemoglobin (HGB), mean corpuscu-
lar hemoglobin (MCH), mean corpuscular hemoglobin
concentration (MCHC), mean corpuscular volume
(MCV) and platelet counts [22] were determined in con-
trol and MXGST extract-treated groups. The serum was
carefully aspirated into sample bottles for various bio-
chemical assays. Aspartate transaminase (AST), alanine
transaminase (ALT), creatinine, blood glucose, blood
urea nitrogen (BUN), total protein and albumin analyses
were determined using Radox diagnostic assay kits.
Organs weight and histology
The rats were quickly dissected and major organs, in-
cluding the brain, heart, lung, liver, spleen, kidney, ad-
renal and testis were excised and weighed. The
specimens for histopathology were fixed in 10 % neu-
tral, buffered formalin for 18 h at 4 °C. The thickness
(4 μm) of each lung, liver and kidney specimen was cut
and stained with hematoxylin and eosin stain according
to standard laboratory procedures. The stained sections
were examined under a microscope for any cellular
damage or change in tissue morphology.
Statistical analysis
All data obtained during antitussive and anti-pyretic ac-
tivity were expressed in terms of the mean and standard
errors, and further analyzed using ANOVA one-way
analysis of variance, which was followed by Scheff ’s
test. When the probability (p) was less than 0.05, the
difference was considered to be significant.
Results
Effects of MXGST extract on citric acid-induced cough in
guinea pigs
The onset time for citric acid-induced cough in normal
animals ranged from 26.9 to 62.4 s, averaging 48.7 s.
The cough incidence in normal animals ranged from 24
to 35 coughs, averaging 29.0. The averaging onset time
for citric acid-induced cough in guinea pig treated with
MXGST at 0.2, 0.4 and 1.0 g/kg was 49.8, 68.8 and
107.7 s, respectively. The averaging cough frequency in
guinea pig treated with MXGST at 0.2, 0.4 and 1.0 g/kg
was 29.5, 21.0 and 13.3, respectively. Hence, MXGST
extract at 0.4–1.0 g/kg decreased the citric acid-
induced cough frequency in a dose-dependent manner
(Fig. 1(b); p < 0.01, p < 0.001), but only at 1.0 g/kg de-
layed the onset time for citric acid-induced cough
(Fig. 1(a); p < 0.001). Aminophylline, a positive control,
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at 125 mg/kg, also decreased the citric acid-induced
cough frequency and delayed the onset time for citric
acid-induced cough (Fig. 1; p < 0.001).
Effects of MXGST extract on the acetylcholine/histamine-
induced bronchial contraction in guinea pigs
The pre-convulsive time of acetylcholine/histamine in-
duced tracheobronchial tonic contraction in guinea pigs
ranged from 48.9 to 89.0 s, averaging 59.3 s. The aver-
aging pre-convulsive time of acetylcholine/histamine
induced tracheobronchial tonic contraction in guinea
pig treated with MXGST at 0.2, 0.4 and 1.0 g/kg was
64.6, 88.5 and 127.6 s, respectively. Hence, MXGST ex-
tract (only at 1.0 g/kg) and aminophylline (125 mg/kg)
delayed the pre-convulsive time of acetylcholine/hista-
mine induced tracheobronchial tonic contraction (Fig. 2;
p < 0.01, p < 0.001).
Effects of MXGST extract on LPS-induced hyperthermia in
rats
The rectal temperature of normal rats maintained at
35.8–36.1 °C. The rectal temperature of LPS-induced
rats was gradually raised from 35.9 to 37.4 °C, and
then maintained at 37.1 °C from 4 to 6 h after LPS in-
jection. So, the rats showed a stable increase in the
rectal temperature immediately after LPS injection
and reached a plateau period in which their rectal
temperature increased approximately 1.5 °C on aver-
age, 3 h after LPS injection (Fig. 3; p < 0.001). The ten-
dency of rectal temperature raised by LPS in rats
treated with MXGST at 0.2 g/kg was similar to that in
LPS-induced rats, and finally their rectal temperature
maintained at 37.0 °C. Treatment with MXGST at
0.4 g/kg, their rectal temperature was raised to 36.5 °C
1 h after LPS injection, and then maintained at 36.2–
36.5 °C. Treatment with MXGST at 1.0 g/kg, their
rectal temperature was raised to 36.3 °C 1 h after LPS
injection, and then maintained at 35.9–36.1 °C. Hence,
Fig. 1 Effect of Ma-Xing-Gan-Shi-Tang (MXGST, 0.2, 0.4, 1.0 g/kg, po) and aminophylline (125 mg/kg, po) on (a) the onset time and (b) the
frequency of citric acid-induced cough response in guinea pig. Each values are represented as mean ± S.E. (N = 6). ** p < 0.01, *** p < 0.001 as
compared with the normal group
Fig. 2 Effect of Ma-Xing-Gan-Shi-Tang (MXGST, 0.2, 0.4, 1.0 g/kg, po)
and aminophylline (125 mg/kg, po) on the pre-convulsive time of
acetylcholine/serotonin-induced tracheobronchial tonic contraction
in guinea pig. Each values are represented as mean ± S.E. (N = 6). **
p < 0.01, *** p < 0.001 as compared with the normal group
Fig. 3 Effect of Ma-Xing-Gan-Shi-Tang (MXGST, 0.2, 0.4, 1.0 g/kg, po)
on the lipopolysaccharide (LPS, 100 μg/kg, ip)-induced hyperthermia
in rats. Each values are represented as mean ± S.E. (N = 6). * p < 0.05,
** p < 0.01, *** p < 0.001, as compared with the LPS group
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MXGST extract, at 0.4 and 1.0 g/kg, produced signifi-
cant anti-pyretic activity from 2 to 6 h after LPS injec-
tion in a dose-dependent manner (Fig. 3; p < 0.05 and
p < 0.01).
Sub-acute toxicology of MXGST extract
Average body weight of all rats before any treatment
was 230 gm. After eight treatment with vehicle, 0.4,
1.0 or 2.0 g/kg of MXGST, their average body weight
of each group was 405.8 ± 14.6, 399.8 ± 17.7, 388.0 ±
9.6, and 386.2 ± 12.7 gm, respectively. Oral treatment
with MXGST extract at 1.0 or 2.0 g/kg for 28-days
caused a slight tendency in body weight loss in a dose-
dependent manner, but this was not significant
compared with the control group (Fig. 4(a) and (b)).
Again, there were no significant difference in the
hematological parameters including RBC, HGB, HCT,
MCV, MCH, MCHC, WBC and platelet counts be-
tween rats treated with MXGST extract (0.4, 1.0 or
2.0 g/kg) or vehicle (Table 2, p > 0.05). The biochem-
ical parameters for liver and kidney function tests,
such as AST, ALT, creatinine, BUN, blood glucose,
total protein and albumin, of rats treated with
MXGST extract (0.4, 1.0 or 2.0 g/kg) were not signifi-
cantly different from those of the control group
(Table 3, p > 0.05). The urine parameters, including
the volume, pH value, protein and glucose, of rats
treated with MXGST extract at 0.4, 1.0 or 2.0 g/kg
were not significantly different from those of the con-
trol group (Table 4, p > 0.05). Finally, there were no
significant difference between rats treated with
MXGST extract (0.4, 1.0 or 2.0 g/kg) or vehicle in
their mean weights and gross examinations of major
organs, including the brain, heart, lungs, liver, spleen,
kidneys, adrenal glands and testis dissected from all
rats (Table 5, p > 0.05). When MXGST was adminis-
tered at a higher dose (2.0 g/kg) for 28 days, no histo-
pathological changes in the lungs, liver or kidneys
were observed (Fig. 5).
Discussion
MXGST is mainly used by traditional Chinese physi-
cians to treat cough from pneumonia. A recent report
indicated that MXGST prolonged the coughing onset
and decreased the coughing frequency of ammonia-
induced cough in rats [23]. Citric acid-induced cough
is a very useful model for assessing the antitussive ef-
fects of medicinal plants and synthetic compounds.
Hence, we first performed a citric acid-induced cough
to evaluate the antitussive effects of MXGST extract
in guinea pigs. The dosage (0.4 g/kg) of MXGST was
chosen according to the conversion of the clinical
daily therapeutic dosage [5] to animal equivalent dos-
age by body surface area and other reports [6, 7, 23].
The present data are similar to the effects of MXGST
on ammonia-induced cough [23], indicating that
Fig. 4 Effect of Ma-Xing-Gan-Shi-Tang (MXGST, 0.4, 1.0, 2.0 g/kg, po) on (a) the tendency of body weight and (b) daily food intake during 28-day
repeated treatment in rats. Each value are represented as mean ± S.E. (N = 6)
Table 2 Effects of Ma-Xing-Gan-Shi-Tang (MXGST, 0.4, 1.0, 2.0 g/kg, po) after 28-day repeated oral administration on hematological
parameters in rats
Groups RBC (106 cells/μL) HGB (g/dL) MCV (fj) MCH (pg) MCHC (g/dL) HCT (%) WBC (103 cells/μL) Platelet (103 cells/μL)
Normal 7.1 ± 0.3 14.7 ± 0.4 59.0 ± 0.8 20.9 ± 0.4 35.5 ± 0.8 41.5 ± 1.5 8.9 ± 1.2 784.5 ± 68.6
MXGST 0.4 g/kg 7.0 ± 0.1 15.1 ± 0.2 59.3 ± 1.3 21.6 ± 0.3 36.5 ± 0.6 41.6 ± 1.1 9.2 ± 1.5 816.2 ± 42.3
MXGST 1.0 g/kg 6.8 ± 0.1 14.7 ± 0.2 58.0 ± 1.1 21.6 ± 0.3 37.3 ± 0.5 39.5 ± 1.0 8.0 ± 1.0 839.7 ± 36.8
MXGST 2.0 g/kg 7.3 ± 0.2 15.6 ± 0.3 58.7 ± 1.2 21.5 ± 0.3 36.7 ± 0.5 42.6 ± 1.2 10.9 ± 1.2 936.2 ± 55.9
Data are represented with mean ± SEM, N = 6
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MXGST and the aminophylline positive control had
antitussive effects on the citric acid-induced cough
model. Furthermore, citric acid stimulated rapidly
adapting, histaminergic and acetylcholinergic recep-
tors that are located in the larynx and upper airways
of the tracheobronchial tree by opening the pH gated
ion channels to induce cough and tracheobronchial
contraction [2]. The inhalation of citric acid also
causes bronchial hyperresponsiveness to acetylcholine
and hypersensitivity to histamine-induced microvascu-
lar leakage, which can then induce tracheobronchial
contraction and cough [2]. As a result, the antitussive
mechanism of MXGST extract on the bronchial tract
was explored by acetylcholine/histamine-induced tra-
cheobronchial contraction in guinea pigs. We also
found that MXGST and positive control aminophylline
relaxed the tracheobronchial contraction caused by
acetylcholine/histamine. Another researcher indicated
that MXGST relieved airway resistance increases by
Dermatophagoides Pteronyssinus in guinea pigs [7].
Moreover, Ephedrae possessed the antitussive effects
of citric acid-induced cough in guinea pigs [24]. Add-
itionally, ephedrine and methylephedrine (both active
ingredients of Ephedrae) have antitussive and anti-
asthmatic effects in animal models and humans. They
can dilate bronchial smooth muscle via activating both
sympathomimetic α- and β-adrenergic receptors [25,
26]. Amygdalin, a major constituent of Semen Pruni
Armeniacae, also possesses antitussive activities via
inhibiting the central cough center when it is biotrans-
formed into cyanide, an active ingredient [25]. Licorice
also decreased the cough response induced by
ammonia or capsaicin [27, 28]. Moreover, co-
treatment with Ephedrae and Semen Pruni Armenia-
cae has better antitussive effects than Ephedrae or
Semen Pruni Armeniacae alone [9]. Thus, we sug-
gested that MXGST extract, at a lower dosage than
the reported dosage of each medicinal component,
possessed antitussive effects. These effects might be
due to the synergic effects of its medicinal compo-
nents, especially of Ephedrae and Semen Pruni Arme-
niacae [9]. The antitussive mechanism of MXGST
might be related to dilating the bronchial smooth
muscle by inhibiting the histaminergic and acetylcholi-
nergic receptors in the bronchial tract, activating both
sympathomimetic α- and β-adrenergic receptors from
ephedra alkaloids and inhibiting the central cough
center from amygdalin [25, 26]. However, citric acid-
induced cough and tracheobronchial constriction are
partially mediated by the nonadrenergic–noncholiner-
gic-nonhistaminergic nervous systems, which include
tachykinins, leukotrienes and prostaglandin E2 from
mast cells [29–33]. Therefore, whether the antitussive
mechanism of MXGST might be related to stabilizing
mast cells and inhibiting other inflammatory media-
tors and nervous systems must be investigated in the
future.
Second, the anti-pyretic effects of MXGST extract on
LPS-induced hyperthermia in rats were evaluated be-
cause traditional Chinese physicians mainly use
MXGST to treat fever caused by pneumonia. This re-
sult is consistent with other report that MXGST pos-
sesses anti-pyretic effects on a typhoid/paratyphoid
vaccine-induced fever model in rabbits [6]. Some re-
searchers indicated that Gypsum possesses anti-pyretic
effects in Brewer’s yeast-induced hyperthermia via de-
creasing the hypothalamus prostaglandin E2 levels [34].
Glycyrrhetic acid, a major ingredient of licorice, pos-
sesses anti-pyretic effects in Brewer’s yeast-induced
fever in rats via the pituitary adrenal axis [35]. The herb
pairs, Ephedrae and Gypsum, significantly attenuated
Brewer’s yeast-induced fever in rats [36]. Therefore, it
can be suggested that MXGST possesses anti-pyretic
effects via the synergic effects of its medicinal compo-
nents, especially Gypsum and Ephedrae [8, 36], and this
effect might be mediated through the modulation of
Table 3 Effects of Ma-Xing-Gan-Shi-Tang (MXGST, 0.4, 1.0, 2.0 g/kg, po) after 28-day repeated oral administration on plasma bio-
chemical parameters in rats
Groups Glu (mg/dL) TP (mg/dL) Albumin (mg/dL) ALT (U/L) AST (U/L) BUN (mg/dL) Creatinine (mg/dL)
Normal 173.8 ± 12.9 5.8 ± 0.4 3.9 ± 0.1 74.1 ± 3.8 73.7 ± 2.7 25.2 ± 2.4 0.29 ± 0.02
MXGST 0.4 g/kg 188.2 ± 3.0 6.2 ± 0.1 3.9 ± 0.1 70.8 ± 5.2 69.3 ± 1.5 27.0 ± 2.4 0.31 ± 0.02
MXGST 1.0 g/kg 185.2 ± 5.4 5.9 ± 0.1 3.8 ± 0.1 65.3 ± 4.0 78.5 ± 6.5 25.3 ± 2.4 0.28 ± 0.02
MXGST 2.0 g/kg 193.0 ± 7.1 6.1 ± 0.2 4.0 ± 0.1 58.5 ± 2.4 71.1 ± 2.2 21.5 ± 1.1 0.30 ± 0.02
Data are represented with mean ± SEM, N = 6
Table 4 Effects of Ma-Xing-Gan-Shi-Tang (MXGST, 0.4, 1.0, 2.0 g/kg,
po) after 28-day repeated oral administration on urine parameters
in rats




Normal 22.0 ± 1.9 7.2 ± 0.1 37.1 ± 2.3 6.9 ± 0.8
MXGST 0.4 g/kg 21.8 ± 2.3 7.1 ± 0.2 38.5 ± 2.9 6.8 ± 0.7
MXGST 1.0 g/kg 21.7 ± 3.3 6.9 ± 0.3 44.0 ± 4.7 6.7 ± 1.5
MXGST 2.0 g/kg 20.2 ± 3.3 6.8 ± 0.1 39.5 ± 2.7 6.8 ± 0.8
Data are represented with mean ± SEM, N = 6
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prostaglandin E2 synthesis in the hypothalamus adrenal
gland axis from glycyrrhizic acid and Gypsum [34, 35].
Each MXGST component has been reported to have
the various adverse effects, such as cardiovascular and
CNS toxicology of Ephedra [11, 12, 18, 19], edema and
mineralocorticoid excess syndrome of licorice [20],
cyanide toxic reaction of Semen Pruni Armeniacae
[13, 14, 17], and allergic response of Gypsum [37].
Therefore, we further evaluated the subacute toxicol-
ogy of MXGST at 0.4, 1.0 or 2.0 g/kg after 28-day re-
peated oral administration in rats because MXGST
possesses antitussive and anti-pyretic effects at doses
of 0.4–1.0 g/kg. Rats treated with MXGST extract at
0.4, 1.0 or 2.0 g/kg body weight daily for 28 days sur-
vived throughout the period and did not show any
changes in their general behavior or other physio-
logical activities. We also found that oral administra-
tion of the MXGST extract at 5 times the effective
dose for 28 days did not cause any toxicological re-
sponses or histopathological changes, and then
MXGST which consists of Ephedrae, Semen Pruni
Armeniacae, licorice and Gypsum did not show any
toxicities such as cardiovascular and CNS toxicology
from Ephedra [11, 12, 18, 19], mineralocorticoid
excess syndrome from licorice [20], cyanide toxic reac-
tion of Semen Pruni Armeniacae [13, 14, 17], and al-
lergic response of Gypsum [37]. Recent reports
indicated that Ephedrae decreased the acute toxicology of
Semen Pruni Armeniacae, and licorice decreased acute
toxicology of Ephedrae when these herb pairs are co-
treated [9, 38]. Therefore, we found that MXGST extract
has a higher safe therapeutic index because the ephedrine
and amygdalin levels in the MXGST extract for the anti-
tussive and anti-pyretic tests are approximately 24–60 μg
ephedrine/g body weight and 176–440 μg amygdalin/g
body weight (thousandth of LD50 dose of ephedrine and
amygdalin).
Conclusion
Based on our present results, MXGST extract is a very
safe Chinese prescription that possesses pronounced
antitussive and anti-pyretic activities, confirming its
clinical utility for cough, bronchial inflammation and
fever caused from pneumonia. The antitussive mechan-
ism of MXGST might be related to dilating the bron-
chial smooth muscle by inhibiting histaminergic and
acetylcholinergic receptors in the bronchial tract, acti-
vating both sympathomimetic α- and β-adrenergic
Table 5 Effects of Ma-Xing-Gan-Shi-Tang (MXGST, 0.4, 1.0, 2.0 g/kg, po) after 28-day repeated oral administration on organ weight in
rats
Groups Brain (g) Heart (g) Lung (g) Liver (g) Spleen (g) Kidney (g) Adrenal (mg)
Normal 1.97 ± 0.05 1.37 ± 0.04 1.38 ± 0.09 15.71 ± 0.56 0.80 ± 0.07 2.71 ± 0.09 61 ± 2
MXGST 0.4 g/kg 1.98 ± 0.03 1.39 ± 0.06 1.45 ± 0.04 15.49 ± 0.71 0.97 ± 0.11 2.73 ± 0.10 59 ± 2
MXGST 1.0 g/kg 1.99 ± 0.04 1.26 ± 0.05 1.34 ± 0.02 14.56 ± 0.43 0.81 ± 0.04 2.57 ± 0.03 57 ± 3
MXGST 2.0 g/kg 2.07 ± 0.04 1.33 ± 0.08 1.44 ± 0.08 15.06 ± 0.69 0.92 ± 0.09 2.57 ± 0.11 60 ± 4
Data are represented with mean ± SEM, N = 6
Fig. 5 Histology of lung, liver and kidney (H&E, 100x) in rats. (a), (c), (e) and (i) Section of lung, liver and kidney from vehicle-treated rats; (b), (d),
(f) and (j) Section of liver and kidney from Ma-Xing-Gan-Shi-Tang (MXGST, 2.0 g/kg, po)-treated rats
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receptors from ephedra alkaloids and inhibiting central
cough center from amygdalin.
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